Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
Bulletin Du Cancer
|
March 12, 2018
Alexandra Frelau, Marc Pracht, Samuel Le Sourd, et al.
Bulletin Du Cancer
|
January 1, 2019
Alexandra Frelau, Marc Pracht, Samuel Le Sourd, et al.
Melanoma Research
|
April 27, 2021
Prognostic impact of thyroid dysfunctions on progression-free survival in patients with metastatic melanoma treated with anti-PD-1 antibodies
Alexandra Frelau, Eva Jali, Boris Campillo-Gimenez, et al.
Cancer Immunology, Immunotherapy : CII
|
September 4, 2020
Increased thyroid uptake on 18F-FDG PET/CT is associated with the development of permanent hypothyroidism in stage IV melanoma patients treated with anti-PD-1 antibodies
Alexandra Frelau, Xavier Palard-Novello, Eva Jali, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
Bulletin Du Cancer
|
March 12, 2018
Alexandra Frelau, Marc Pracht, Samuel Le Sourd, et al.
Bulletin Du Cancer
|
January 1, 2019
Alexandra Frelau, Marc Pracht, Samuel Le Sourd, et al.
Melanoma Research
|
April 27, 2021
Prognostic impact of thyroid dysfunctions on progression-free survival in patients with metastatic melanoma treated with anti-PD-1 antibodies
Alexandra Frelau, Eva Jali, Boris Campillo-Gimenez, et al.
Cancer Immunology, Immunotherapy : CII
|
September 4, 2020
Increased thyroid uptake on 18F-FDG PET/CT is associated with the development of permanent hypothyroidism in stage IV melanoma patients treated with anti-PD-1 antibodies
Alexandra Frelau, Xavier Palard-Novello, Eva Jali, et al.
Page
of 1